RPRX
Royalty Pharma plc
Key Financials
Operating Income
$1.6B
↑ 20.7%
Revenue
$2.4B
↑ 5.1%
Net Income
$770.9M
↓ 10.2%
EPS (Diluted)
$1.78
↓ 6.8%
Cash & Equivalents
$618.7M
↓ 33.4%
Total Liabilities
$9.9B
↑ 25.7%
Total Assets
$19.6B
↑ 7.7%
Long-term Debt
$9.0B
↑ 17.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RPRX |
| Company Name | Royalty Pharma plc |
| CIK | 1802768 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | (212) 883-0200 |